vitamin b12 injection drug interactions CYANOCOBALAMIN INJECTION, USP 30000 mcg/30 mL (1000 mcg/mL) 30 mL VIAL Medications Known to Decrease Vitamin

Clinical Research Findings on Metabolic Specificity In a comprehensive safety and tolerability study involving approximately 900 participants across six randomized, double-blind, placebo-controlled trials, researchers specifically monitored parameters associated with growth hormones systemic effects

While higher doses (particularly 54 mg) showed some increase in gastrointestinal-related events, these remained mild to moderate in severity and did not result in treatment discontinuation

They are also contraindicated or people with vision problems, Lebers disease, kidney failure, liver failure, folic acid deficiency or any type of systemic infection

The most common methods for injecting Vitamin B12 and / or Vitamin C are either intramuscular or subcutaneous